Skip to main content
FinSpry Logo
FinSpry
ASND logo
ASND
(NASDAQ)
Ascendis Pharma A/S
$253.29-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ascendis Pharma A/S (ASND) Stock Price & Financial Analysis

Ascendis Pharma A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$252.87 - $257.89
52-Week High$282.15
52-Week Low$186.05
Open$253.62
Volume363.76K
Average Volume (3M)522.81K
Market Cap16.75B
Shares Outstanding64.52M
P/E Ratio (TTM)27.21
Price to Sales (P/S)15.83
Price to Book (P/B)28.20
EV/EBITDA-219.44
Revenue (TTM)1.02B
Net Income (TTM)590.94M
Free Cash Flow (TTM)52.00M
EPS (TTM)$9.45
Profit Margin58.20%
Operating Margin-1.18%
Return on Equity (ROE)103.64%
Debt to Equity1.84
50-Day MA$249.42
200-Day MA$228.89
52-Week Change27.47%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Ascendis Pharma A/S

What is the current stock price for ASND?

As of the latest trading session, ASND stock trades at $253.29. The 52-week range is $186.05–$282.15, with a day range of $252.87–$257.88.

What is the P/E ratio for ASND?

Ascendis Pharma A/S's trailing P/E ratio is 27.2, meaning investors pay $27.2 for every $1 of annual earnings. Ascendis Pharma A/S operates in the Healthcare sector.

Does ASND pay dividends?

Ascendis Pharma A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ASND?

Based on 9 analysts, the consensus for ASND is Buy.

What is the market cap of ASND?

Ascendis Pharma A/S's market capitalization is $16.34B, classifying it as a large-cap company. Ascendis Pharma A/S operates in the Healthcare sector within the Biotechnology industry.